Outcomes of Mastoid Obliteration Canal Wall Down Tympanomastoidectomy in Cholesteatoma Surgery

Status

Active, not recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06268938

Enrollment

Registered

2024-02-20

Start date

2023-09-04

Completion date

2028-12-01

Last updated

2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholesteatoma

Brief summary

Randomised study to evaluate the outcomes of mastoid cavity obliteration by muscle versus bone in canal wall down tympanomastoidectomy in cholesteatoma surgery

Detailed description

Regarding discharge Time of epithelizqtion Hearing outcomes Quality of life

Interventions

PROCEDURECanal wall down tympanomastoidectomy

Mastoid cavity obliteration by in canal wall down tympanomastoidectomy tympanomastoidectomy in cholesteatoma surgery

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

5 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* all patients who have extensive or recuutrent cholesteatoma undergoing canal wall down tympanomastoidectomy

Exclusion criteria

* not willing for surgery * Malignancy * Patients with intracranial complication * Residual cholesteatoma

Design outcomes

Primary

Measure	Time frame	Description
Size of mastoid cavity in mm	1 month	Endoscopic examination of the mastoid cavity after 1month to evaluate the degree of epithelization and if there is discharge .

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026